[1] 姚菊芳, 华征宇, 王斌, 等. 近交系侏儒大鼠的培育及其主要生物学特性测定[J]. 实验动物与比较医学, 2016, 36(4): 295-300,306. DOI:10.3969/j.issn.1674-5817.2016.04.010. [2] TORREALDAY S, KODAMAN P, PAL L.Premature Ovarian Insufficiency: an update on recent advances in understanding and management[J]. F1000Res, 2017, 6: 2069. DOI:10.12688/f1000research.11948.1. [3] SVETLANA V, MIOMIRA I, MILINA T, et al.Premature ovarian failure[J]. Srp Arh Celok Lek, 2012, 140(11/12):806-811. DOI:10.2298/sarh1212806v. [4] ANGELIDIS G, DAFOPOULOS K, MESSINI C I, et al.The emerging roles of adiponectin in female reproductive system-associated disorders and pregnancy[J]. Reprod Sci, 2013, 20(8):872-881. DOI:10.1177/1933719112468954. [5] 胡樱, 杨斐, 施映霞, 等. SPF级Wistar大鼠生长发育及繁殖性能的主要指标测定[J]. 实验动物科学与管理, 2003, 20(1): 1-3. DOI:10.3969/j.issn.1006-6179.2003.01.001. [6] 罗满林, 顾为望. 实验动物学[M]. 全松, 陈雷宁译. 北京: 中国农业出版社, 2002: 145-149. [7] DICKEY R P, BRINSDEN P R, PYRZAK R.宫腔内人工授精与促排卵[M]. 全松, 陈雷宁, 译. 北京: 人民卫生出版社, 2011: 19-30. [8] 郑晨思, 郝鸣昭, 许焕芳, 等. 卵巢低反应的诊断标准及中医治疗方法研究进展[J]. 中华中医药杂志, 2020, 35(3):1368-1372. [9] 孔知音. 卵巢功能早衰致不孕症的治疗现状及进展研究[J]. 实用妇科内分泌电子杂志, 2019, 6(34):10-11. DOI: 10.16484/j.cnki.issn2095-8803.2019.34.006. [10] 董若曦, 朱小丹, 樊伯珍, 等. 不同剂量顺铂腹腔注射建立大鼠化疗损伤性卵巢早衰模型[J]. 实验动物与比较医学, 2020, 40(2):104-109. DOI:10. 3969/j.issn.1674-5817.2020.02.003. [11] 向澜, 姚广涛, 李瑞霞, 等. 卵巢功能早衰动物模型建立方法的研究进展[J]. 中国药学杂志, 2015, 50(5):386-389. DOI:10.11669j.2015.05.002. [12] GOSWAMI D, ARIF A, SAXENA A, et al.Idiopathic primary ovarian insufficiency: A study of serial hormonal profiles to assess ovarian follicular activity[J]. Hum Reprod, 2011, 26(8): 2218-2225. DOI:10.1093/humrep/der174. [13] 谢幸, 苟文丽. 妇产科学[M]. 8版. 北京: 人民卫生出版社, 2013: 369. [14] GIANNELOU P, SIMOPOULOU M, GRIGORIADIS S, et al.The conundrum of poor ovarian response: From diagnosis to treatment[J]. Diagnostics, 2020, 10(9):687. DOI:10.3390/diagnostics10090687. [15] DRAKOPOULOS P, BARDHI E, BOUDRY L, et al.Update on the management of poor ovarian response in IVF: The shift from Bologna criteria to the Poseidon concept[J]. Ther Adv Reprod Health, 2020, 14: 2633494120941480. DOI:10.1177/2633494120941480. [16] POLYZOS N P, DEVROEY P. A systematic review of randomized trials for the treatment of poor ovarian responders: Is there any light at the end of the tunnel?[J]. Fertil Steril, 2011, 96(5):1058-1061.e7. DOI:10.1016/j.fertnstert.2011.09.048. [17] REVELLI A, BIASONI V, GENNARELLI G, et al.IVF results in patients with very low serum AMH are significantly affected by chronological age[J]. J Assist Reprod Genet, 2016, 33(5):603-609. DOI:10.1007/s10815-016-0675-7. [18] ZHANG J H, HUANG X X, LIU Y F, et al.A comparison of the effects of Chinese non-pharmaceutical therapies for premature ovarian failure[J]. Medicine, 2020, 99(26): e20958. DOI:10.1097/md.0000000000020958. [19] 宋莹, 吕春梅, 王娇, 等. MicroRNA与卵巢功能关系的研究进展[J]. 解剖科学进展, 2017, 23(6): 645-648. DOI:10.16695/j.cnki.1006-2947.2017.06.026. [20] 鄢雯影, 李蓉, 汤彪. MicroRNAs 在卵巢功能中的调节作用[J]. 中国妇产科临床杂志, 2020, 21(5):558-560. DOI: 10.13390/j.issn.1672-1861.2020.05.045. [21] KUANG H X, HAN D W, XIE J M, et al.Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model[J]. Gynecol Endocrinol, 2014, 30(1):57-61. DOI:10.3109/09513590.2013.850659. [22] CHEN Z, CHEN H, YUAN K, et al.A 15q25.2 microdeletion phenotype for premature ovarian failure in a Chinese girl: A case report and review of literature[J]. BMC Med Genomics, 2020, 13(1):126. DOI:10.1186/s12920-020-00787-w. [23] 陈丽平, 刘丹, 梁辉标, 等. 儿茶酚-O-甲基转移酶基因功能区单核苷酸多态性及甲基化水平与卵巢早衰的相关性[J]. 西安交通大学学报(医学版), 2019, 40(3):432-436. DOI:10.7652yxb201903017. |